The Medicines Patent Pool announced a licence today with MSD, known as Merck in the United States and Canada, for paediatric formulations of raltegravir, a key medicine approved for children living with HIV four weeks of age and older.
from The Medical News http://ift.tt/1w75LcY
from The Medical News http://ift.tt/1w75LcY
No comments:
Post a Comment